| 标题 |
Afatinib versus placebo for patients with advanced, metastatic non-small-cell lung cancer after failure of erlotinib, gefitinib, or both, and one or two lines of chemotherapy (LUX-Lung 1): a phase 2b/3 randomised trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:Lancet Oncology 作者:Vincent A. Miller; Vera Hirsh; Jacques Cadranel; Yuh-Min Chen; Keunchil Park; et al 出版日期:2012-03-25 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)